Month: May 2021

14959-32-1, Name is 3-Chloro-6-(methylamino)pyridazine, belongs to pyridazine compound, is a common compound. Recommanded Product: 3-Chloro-6-(methylamino)pyridazineIn an article, once mentioned the new application about 14959-32-1.

2-ARYLBENZOTHIOPHENE DERIVATIVES OR PHARCEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF, AND PHARCEUTICAL COMPOSITION FOR THE DIAGNOSIS OR TREATMENT OF DEGENERATIVE BRAIN DISEASE CONTAINING THE SAME AS ACTIVE INGREDIENT

2-arylbenzothiophene derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient. Since the 2-arylbenzothiophene derivatives of Formula 1 have a relatively high binding affinity for beta-amyloid, they can be used as diagnostic reagents for diagnosing Alzheimer’s disease at an early stage by non-invasive techniques when they are labeled with radioisotopes: wherein R1-R4, V, W, X, Y and Z are as defined in the Detailed Descript of the specification. Further, when the pharmaceutical composition containing the 2-arylbenzothiophene derivative binds with a low-molecular weight beta-amyloid peptide binding compound, generation of malignant high-molecular weight beta-amyloid deposits is minimized. Accordingly, the pharmaceutical composition can be used as a therapeutic agent of degenerative brain disease such as Alzheimer’s disease

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 14959-32-1

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N1025 – PubChem

 

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. Formula: C4H2Br2N2O. Introducing a new discovery about 5788-58-9, Name is 4,5-Dibromopyridazin-3(2H)-one

HETEROARYLPIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is directed to compounds of the formula (I): (wherein R1, R2, R3, R4, R5, R6, R10 and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Formula: C4H2Br2N2O, you can also check out more blogs about5788-58-9

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N3159 – PubChem

 

Chemistry is an experimental science, and the best way to enjoy it and learn about it is performing experiments. Computed Properties of C4H2Cl2N2O. Introducing a new discovery about 932-22-9, Name is 4,5-Dichloro-3(2H)-pyridazinone

Access to 4-alkylaminopyridazine derivatives via nitrogen-assisted regioselective pd-catalyzed reactions

3-Substituted, 6-substituted, and unsymmetrical 3,6-disubstituted 4-alkylaminopyridazines were prepared from a sequence of three chemo- and regioselective reactions combining amination and palladium-catalyzed cross-coupling reactions, such as reductive dehalogenation and Suzuki-Miyaura reactions. Extension of the methodology to Sonogashira reaction yielded a novel class of 3-substituted pyrrolopyridazines.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Computed Properties of C4H2Cl2N2O, you can also check out more blogs about932-22-9

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2298 – PubChem

 

Electric Literature of 65202-50-8, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.65202-50-8, Name is Methyl 6-chloropyridazine-3-carboxylate, molecular formula is C6H5ClN2O2. In a Patent，once mentioned of 65202-50-8

VINYL COMPOUNDS AS FGFR AND VEGFR INHIBITORS

FGFR and VEGFR inhibitors are provided, and compounds represented by formula (1) or formula (II) as FGFR and VEGFR inhibitors, pharmaceutically acceptable salts or tautomers thereof are specifically disclosed.

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 65202-50-8

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2405 – PubChem

 

20375-65-9, Name is 3-Phenyl-6-chloropyridazine, belongs to pyridazine compound, is a common compound. Product Details of 20375-65-9In an article, once mentioned the new application about 20375-65-9.

SOLUTION SYNTHESIS OF N-METHYLATED PEPTIDES BY THE DIPHENYL PHOSPHINIC MIXED ANHYDRIDE PROCEDURE

A proton NMR method has been used to monitor racemisation during the coupling of N-methylated amino acids by the diphenylphosphinic mixed anhydride procedure.No racemisation was observed when urethane protection employed, but use of the benzoyl group led extensive racemisation.The reagent was subsequently used for the assembly of several extensively N-methylated peptides.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 20375-65-9

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2629 – PubChem

 

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 5469-70-5, name is 3-Aminopyridazine, introducing its new discovery. Application In Synthesis of 3-Aminopyridazine

CuI-catalyzed amination of arylhalides with guanidines or amidines: A facile synthesis of 1-H-2-substituted benzimidazoles

(Figure Presented) CuI/L5 (N,N?-dimethylethylenediamine) proves to be an efficient catalyst system for the amination of arylhalides with guanidines. The same catalyst system is then successfully applied to the one-step synthesis of 1-H-2-aminobenzimidazoles through tandem aminations of 1,2-dihaloarenes in modest yields. This methodology is also applicable for the preparation of 1-H or 1-substutituted 2-aryl- or 2-alkyl-benzimidazoles.

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 5469-70-5, and how the biochemistry of the body works.Application In Synthesis of 3-Aminopyridazine

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N70 – PubChem

 

141-30-0, Name is 3,6-Dichloropyridazine, belongs to pyridazine compound, is a common compound. SDS of cas: 141-30-0In an article, once mentioned the new application about 141-30-0.

3-[(6-Arylamino)pyridazinylamino]benzoic acids: Design, synthesis and in vitro evaluation of anticancer activity

A series of novel substituted 3,6-disubstituted pyridazines based on the structure of vatalanib (PTK787) were designed and synthesized. The cytotoxicity of the final compounds was tested in vitro on HT-29 colon cancer cell line. Compounds 2a and 2b with 4-chlorophenylamino moiety, exerted the highest cytotoxic activity with IC50 values equal to 15.3 and 3.9 muM respectively. The most promising compound, 2b, was found to be about fivefold more active than vatalanib against HT-29 colon cancer cell line.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 141-30-0

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N1585 – PubChem

 

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 5096-73-1, name is 6-Chloropyridazine-3-carboxylic acid, introducing its new discovery. Recommanded Product: 5096-73-1

Palladium-catalyzed highly regioselective Mizoroki-heck arylation of allylamines with aryl chlorides

Palladium catalyst systems for the regioselective Mizoroki-Heck arylation of N,N-diprotected and N-protected allylamines with aryl chlorides have been developed. Pd(OAc)2 in combination with appropriate additives could efficiently catalyze the linear arylation of N,N-diprotected allylamines with aryl chlorides in toluene to give exclusively the gamma-arylated products in good to excellent yields and with excellent regio- and stereocontrol and good functional group tolerance. With use of a catalytic mixture of Pd(OAc) 2 and 1,1′-bis(diphenylphosphino)ferrocene, the arylation of N-protected allylamines with aryl chlorides could be accomplished in ethylene glycol/DMSO, which afforded complete beta-regioselectivity with good functional group tolerance. The steric and electronic properties of allylamine substrates are found to be critical to the catalytic activity and regiocontrol in both linear and internal arylations. Copyright

We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 5096-73-1, and how the biochemistry of the body works.Recommanded Product: 5096-73-1

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2075 – PubChem

 

Electric Literature of 141-30-0, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 141-30-0, Name is 3,6-Dichloropyridazine, molecular formula is C4H2Cl2N2. In a Article，once mentioned of 141-30-0

Iron-Mediated Electrophilic Amination of Organozinc Halides using Organic Azides

A wide range of alkyl-, aryl- and heteroarylzinc halides were aminated with highly functionalized alkyl, aryl, and heterocyclic azides. The reaction proceeds smoothly at 50 C within 1 h in the presence of FeCl3 (0.5 equiv) to furnish the corresponding secondary amines in good yields. This method was extended to peptidic azides and provided the arylated substrates with full retention of configuration. To demonstrate the utility of this reaction, we prepared two amine derivatives of pharmaceutical relevance using this iron-mediated electrophilic amination as the key step.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Electric Literature of 141-30-0. In my other articles, you can also check out more blogs about 141-30-0

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N1712 – PubChem

 

Related Products of 115514-66-4, Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics.In a document type is Patent, and a compound is mentioned, 115514-66-4, 4-Bromopyridazine, introducing its new discovery.

TETRAHYDROISOQUINOLINE DERIVED PRMT5-INHIBITORS

A compound of formula I wherein: n is 1 or 2: p is 0 or 1; R1 is optionally one or more halo or methyl groups; R2a and R2b are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH2OH; R2c and R2d are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH2OH; R3a and R3b are independently selected from H and Me; R4 is either H or Me; R5 is either H or Me; R6a and R6b are independently selected from H and Me; A is either (i) optionally substituted phenyl; (ii) optionally substituted naphthyl; or (iii) optionally substituted C5-12 heteroaryl.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Related Products of 115514-66-4. In my other articles, you can also check out more blogs about 115514-66-4

Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2095 – PubChem